ACNP 2024
NeuroKaire attended the ACNP Annual Meeting 2024, showcasing our innovative approach to precision psychiatry. Dr. Talia Cohen Solal, our CEO and Co-founder, presented a poster on utilizing patient-derived neurons to advance personalized mental health treatments.
NeuroKaire participated in the 2024 ACNP Annual Meeting, a prestigious gathering of leaders in neuroscience and psychiatry. The event served as a platform to share our vision for advancing precision psychiatry and its role in transforming mental health care.
Our CEO and Co-founder, Dr. Talia Cohen Solal, presented a poster titled “Precision Psychiatry Using hiPSC Derived Neurons: Assessing Synaptic Connectivity as a Biomarker for Drug Response” (Poster W71). This research highlights the use of patient-derived neurons to better understand antidepressant mechanisms and response timeframes, offering new pathways for personalized mental health treatments.
The meeting provided an incredible opportunity to engage with thought leaders, exchange ideas, and further our mission to bring innovative solutions to clinicians and patients worldwide.
Schedule a Meet & Greet
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel